MedPath

三门峡赛诺维制药有限公司

Ownership
-
Established
2001-08-08
Employees
-
Market Cap
-
Website
http://www.sinowaypharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

37

NMPA:37

Drug Approvals

Loratadine

Product Name
氯雷他定
Approval Number
国药准字H20020173
Approval Date
Oct 30, 2024
NMPA

Aluminium Hydroxide

Product Name
氢氧化铝
Approval Number
国药准字H41021183
Approval Date
Oct 30, 2024
NMPA

Zalepon

Product Name
扎来普隆
Approval Number
国药准字H20031052
Approval Date
Oct 30, 2024
NMPA

石黄抗菌胶囊

Approval Number
国药准字Z20090108
Approval Date
Jan 23, 2024
NMPA

Sodium Nitroprusside

Product Name
硝普钠
Approval Number
国药准字H20113357
Approval Date
Jun 24, 2020
NMPA

Inosine Tablets

Product Name
肌苷片
Approval Number
国药准字H41023460
Approval Date
Apr 22, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H41022200
Approval Date
Apr 22, 2020
NMPA

Zaleplon Dispersible Tablets

Product Name
安云
Approval Number
国药准字H20040035
Approval Date
Apr 22, 2020
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H41023461
Approval Date
Apr 22, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H41021353
Approval Date
Apr 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy